C4 Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
C4 Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q2 2024.
  • C4 Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 30, 2024 was 69.3M shares, a 41% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 69.3M +20.1M +41% Jul 30, 2024 10-Q 2024-08-01
Q1 2024 68.8M +19.7M +40.2% Apr 30, 2024 10-Q 2024-05-08
Q4 2023 68.6M Feb 14, 2024 10-K 2024-02-22
Q3 2023 49.3M +324K +0.66% Oct 25, 2023 10-Q 2023-11-01
Q2 2023 49.2M +277K +0.57% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 49.1M +267K +0.55% Apr 25, 2023 10-Q 2023-05-04
Q3 2022 49M +331K +0.68% Oct 26, 2022 10-Q 2022-11-03
Q2 2022 48.9M +459K +0.95% Jul 27, 2022 10-Q 2022-08-04
Q1 2022 48.8M +5.68M +13.2% Apr 25, 2022 10-Q 2022-05-05
Q3 2021 48.6M +5.6M +13% Nov 1, 2021 10-Q 2021-11-10
Q2 2021 48.5M Aug 2, 2021 10-Q 2021-08-11
Q1 2021 43.1M Mar 1, 2021 10-K 2021-03-11
Q3 2020 43M Nov 10, 2020 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.